vs
Side-by-side financial comparison of dLocal Ltd (DLO) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $337.9M, roughly 1.5× dLocal Ltd). dLocal Ltd runs the higher net margin — 16.5% vs 6.8%, a 9.6% gap on every dollar of revenue. On growth, dLocal Ltd posted the faster year-over-year revenue change (65.2% vs -1.7%).
dLocal Limited is a Uruguayan financial technology company. It provides cross-border payments connecting global merchants to emerging markets.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
DLO vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $337.9M | $493.8M |
| Net Profit | $55.6M | $33.7M |
| Gross Margin | 34.3% | — |
| Operating Margin | 18.6% | 9.9% |
| Net Margin | 16.5% | 6.8% |
| Revenue YoY | 65.2% | -1.7% |
| Net Profit YoY | 87.3% | 10.5% |
| EPS (diluted) | $0.18 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $337.9M | $493.8M | ||
| Q3 25 | $282.5M | $492.9M | ||
| Q2 25 | — | $468.8M | ||
| Q1 25 | — | $458.4M | ||
| Q4 24 | $204.5M | $502.4M | ||
| Q3 24 | $185.8M | $511.2M | ||
| Q2 24 | — | $504.3M | ||
| Q1 24 | — | $495.1M |
| Q4 25 | $55.6M | $33.7M | ||
| Q3 25 | $141.3M | $71.7M | ||
| Q2 25 | — | $39.3M | ||
| Q1 25 | — | $20.7M | ||
| Q4 24 | $29.7M | $30.5M | ||
| Q3 24 | $90.8M | $19.4M | ||
| Q2 24 | — | $-153.0M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | 34.3% | — | ||
| Q3 25 | 36.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 40.9% | — | ||
| Q3 24 | 42.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 18.6% | 9.9% | ||
| Q3 25 | 19.7% | 13.8% | ||
| Q2 25 | — | 12.8% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | 20.7% | 7.8% | ||
| Q3 24 | 22.1% | 6.6% | ||
| Q2 24 | — | -31.3% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | 16.5% | 6.8% | ||
| Q3 25 | 50.0% | 14.5% | ||
| Q2 25 | — | 8.4% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | 14.5% | 6.1% | ||
| Q3 24 | 48.9% | 3.8% | ||
| Q2 24 | — | -30.3% | ||
| Q1 24 | — | 0.8% |
| Q4 25 | $0.18 | $0.40 | ||
| Q3 25 | $0.17 | $0.84 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.24 | ||
| Q4 24 | $0.09 | $0.37 | ||
| Q3 24 | $0.09 | $0.23 | ||
| Q2 24 | — | $-1.84 | ||
| Q1 24 | — | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $719.9M | $375.2M |
| Total DebtLower is stronger | $86.7M | $570.5M |
| Stockholders' EquityBook value | $569.4M | $865.9M |
| Total Assets | $1.5B | $2.2B |
| Debt / EquityLower = less leverage | 0.15× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $719.9M | $375.2M | ||
| Q3 25 | $604.5M | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | $425.2M | $229.9M | ||
| Q3 24 | $560.5M | $103.8M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $8.0M |
| Q4 25 | $86.7M | $570.5M | ||
| Q3 25 | $63.1M | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | $39.8M | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $569.4M | $865.9M | ||
| Q3 25 | $504.7M | $890.7M | ||
| Q2 25 | — | $833.8M | ||
| Q1 25 | — | $789.2M | ||
| Q4 24 | $489.0M | $764.9M | ||
| Q3 24 | $457.0M | $732.5M | ||
| Q2 24 | — | $706.5M | ||
| Q1 24 | — | $856.2M |
| Q4 25 | $1.5B | $2.2B | ||
| Q3 25 | $1.4B | $2.2B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | $1.2B | $2.2B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.2B |
| Q4 25 | 0.15× | 0.66× | ||
| Q3 25 | 0.12× | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | 0.08× | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $100.4M | $114.1M |
| Free Cash FlowOCF − Capex | $99.8M | — |
| FCF MarginFCF / Revenue | 29.5% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 1.80× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $378.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $100.4M | $114.1M | ||
| Q3 25 | $315.0M | $137.3M | ||
| Q2 25 | — | $137.2M | ||
| Q1 25 | — | $-117.5M | ||
| Q4 24 | $-141.1M | $133.0M | ||
| Q3 24 | $108.3M | $91.8M | ||
| Q2 24 | — | $107.0M | ||
| Q1 24 | — | $-125.2M |
| Q4 25 | $99.8M | — | ||
| Q3 25 | $313.4M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-141.6M | — | ||
| Q3 24 | $107.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 29.5% | — | ||
| Q3 25 | 110.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -69.2% | — | ||
| Q3 24 | 57.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 1.80× | 3.39× | ||
| Q3 25 | 2.23× | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | -4.75× | 4.36× | ||
| Q3 24 | 1.19× | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DLO
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
